
Overview
Dr Joanna Sanford is the founder of Sanford Biotech, which develops stem cell therapies and growth factor treatments for both human and veterinary medicine. The company conducts translational research to create commercial cell therapies with high licensing potential, including innovative treatments for conditions like arthritis in dogs and atopic dermatitis in pets. Additionally, Sanford Biotech is involved in advanced therapies for horses and dairy cattle, reflecting a shift in the care of these animals towards more human-like medical attention.
Financials
Revenue history (in k)
Filing timeliness
4 of 6 financial statements were filed late (the longest delay 130 days for 2021).
- 202514/07/2026
- 202410/07/2025
- 202304/11/2024
- 202218/07/2023
- 202122/11/2022
- 202018/11/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Stem cell therapies
- Platelet-rich plasma therapy
- Biological therapies
- Translational research
- Veterinary therapies
Websites
- sanfordbiotech.comSanford Biotech | komórki macierzyste i badania translacyjneGoogle AnalyticsGoogle Tag ManagerLLiteSpeed
Partners
| Partners |
|---|
Piotr Paweł Brendota age 55 |
Joanna Sanford age 59 |
Manner of representation
Each partner authorized to represent the company has the right to represent the company independently.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2017-11-01.
28 1050 1025 1000 0090 8023 6806
Debt
No entries in the National Debtors Register (KRZ).
Public aid
68 public aid cases recorded, with a total value of $22,848.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 16, 2024 | Aid in the form of wage subsidies for the recruitment of workers with disabilities | $338$338 | Prezes Zarządu Państwowego Funduszu Rehabilitacji Osób Niepełnosprawnych | |
| Jun 13, 2024 | Aid in the form of wage subsidies for the recruitment of workers with disabilities | $338$338 | Prezes Zarządu Państwowego Funduszu Rehabilitacji Osób Niepełnosprawnych | |
| May 16, 2024 | Aid in the form of wage subsidies for the recruitment of workers with disabilities | $338$338 | Prezes Zarządu Państwowego Funduszu Rehabilitacji Osób Niepełnosprawnych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| ETG Zamość sp. z o.o. | $260,151.02 | etg-network.com | ||
| Nanosanguis S.A. | $192,701.50 | nanosanguis.com | ||
| Medesto sp. z o.o. | $120,911.45 | medesto.com.pl | ||
| WPD Pharmaceuticals S.A. | $87,561.70 | wpdpharmaceuticals.pl | ||
| Orphinic Scientific S.A. | $42,972.42 | orphinic.com | ||
| Bonereg sp. z o.o. | $25,113.01 | bonereg.com | ||
| Cellis sp. z o.o. | $24,935.59 | cellis.eu | ||
| Nanovelos S.A. | $24,842.03 | nanovelos.com | ||
| Microbiota Med sp. z o.o. | $7,423.69 | microbiota-med.com | ||
| Omniseptica sp. z o.o. | $3,475.29 | omniseptica.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-09-29 | Name change (Sanford Biotech → Dr Joanna Sanford) | |
| 2025-09-29 | Switch to PKD 2025 (1 PKD 2007 code → 4 PKD 2025 codes) | |
| 2017-09-07 | Entered in the register |
FAQ
Last updated: 2026-07-17